Effectiveness of Bupropion Sustained Release for Smoking Cessation in a Health Care Setting
Archives of Internal MedicinePublished 27 October 2003
Gary E. Swan, Tim McAfee, Susan J. Curry, Lisa M. Jack, Harold S. Javitz, Sara Dacey
Citations142
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The combination of bupropion SR and minimal or moderate counseling was associated with 1-year quit rates of 23.6% to 33.2% in this actual practice setting, suggesting that existing health care systems can substantially decrease tobacco use rates among their enrollees if they provide these modest interventions.
Abstract
In this actual practice setting, the combination of bupropion SR and minimal or moderate counseling was associated with 1-year quit rates of 23.6% to 33.2%. This suggests that existing health care systems can substantially decrease tobacco use rates among their enrollees if they provide these modest interventions.
Keywords
PsychologyMedicine
British Journal of AddictionThe Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
10,770 Citations1991Todd F. Heatherton, Lynn T. Kozlowski +2 more
A revision of the FTQ: the Fagerström Test for Nicotine Dependence (FTND), which found that a revised scoring of time to the first cigarette of the day (TTF) and number of cigarettes smoked per day (CPD) improved the scale.
Systems Research and Behavioral ScienceThe Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
4,656 Citations1974Leonard R. Derogatis, Ronald S. Lipman +3 more
The historical evolution, development, rationale and validation of the Hopkins Symptom Checklist is described, a self-report symptom inventory comprised of 58 items which are representative of the symptom configurations commonly observed among outpatients.
Nicotine & Tobacco ResearchBiochemical verification of tobacco use and cessation
1,839 Citations2002Neal L. Benowitz, Peyton Jacob +10 more
American Journal of Public HealthThe validity of self-reported smoking: a review and meta-analysis.
1,752 Citations1994Donald L. Patrick, Allen Cheadle +4 more
Self-reports of smoking are accurate in most studies, but biochemical assessment, preferably with cotinine plasma, should be considered in intervention studies and student populations to improve accuracy.
New England Journal of MedicineA Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking Cessation
1,601 Citations1999Douglas E. Jorenby, Scott J. Leischow +10 more
Treatment with sustained-release bupropion alone or in combination with a nicotine patch resulted in significantly higher long-term rates of smoking cessation than use of either the nicotine patch alone or placebo.
New England Journal of MedicineA Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
1,266 Citations1997R. Douglas Hurt, David P.L. Sachs +10 more
A double-blind, placebo-controlled trial of a sustained-release form of bupropion for smoking cessation, which excluded smokers with current depression, but not those with a history of major depression.
Clinical TherapeuticsMethods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice
894 Citations1999Kevin C. Farmer
Researchers and clinicians have used numerous methods in their attempts to adequately assess patient compliance (adherence) with medication regimens and to identify noncompliant patients, but the choice of a method should be based on the usefulness and reliability of the method in light of the researcher's or clinician's goals.
Psychological BulletinAssessing outcome in smoking cessation studies.
800 Citations1992Wayne F. Velicer, James O. Prochaska +2 more
Outcome measures for smoking cessation are reviewed and evaluated, including 3 self-report measures and 3 biochemical validation measures, primarily measures of point prevalence abstinence.
JAMAA Clinical Practice Guideline for Treating Tobacco Use and Dependence: A US Public Health Service Report
795 Citations2000Staff The Tobacco Use and Dependence Clinical Practice Guideline Panel
The recently published US Public Health Service report Treating Tobacco Use and Dependence: A Clinical Practice Guideline provides recommendations for briefclinical interventions, intensive clinical interventions, and system changes to promote the treatment of tobacco dependence.
Annals of Internal MedicineUsing Numerical Results from Systematic Reviews in Clinical Practice
461 Citations1997Henry J McQuay, R. Andrew Moore
This paper provides guidance on how to interpret the numerical and statistical results of systematic reviews, translate these results into more understandable terms, and apply them directly to individual patients.
The LancetSmoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial
416 Citations2001DP Tashkin, Richard E. Kanner +8 more
Bupropion SR is a well-tolerated and effective aid to smoking cessation in people with mild to moderate COPD and symptoms of tobacco craving and withdrawal were attenuated in those receiving bupropion SR.
Journal of Consulting and Clinical PsychologySelf-help quit smoking interventions: Effects of self-help materials, social support instructions, and telephone counseling.
267 Citations1991C. Tracy Orleans, Victor J. Schoenbach +3 more
Controlled Clinical TrialsMeasuring Adherence to Behavioral and Medical Interventions
239 Citations2000Mara Z. Vitolins, Cynthia S. Rand +3 more
Adherence to pharmacological interventions is assessed using self-report methods, biochemical measures, medication counts, and the automated pharmacy database review strategy; the strengths and weaknesses of these methods are reviewed.
Addictive BehaviorsBiochemical validation of smoking status: Pros, cons, and data from four low-intensity intervention trials
181 Citations1993Russell E. Glasgow, John P. Mullooly +8 more
Questions are raised about whether biochemical validation procedures are practical, informative, or cost-effective in such population-based, low-intensity intervention research.
Journal of Clinical EpidemiologyCost-effectiveness comparisons using “real world” randomized trials: The case of new antidepressant drugs
149 Citations1995GE Simon
The authors describe the design of such a "real world" randomized trial comparing newer antidepressants with older alternatives and use available data on the cost-effectiveness of new antidepressant drugs to illustrate the limitations of these methods.
Clinical Pharmacology & TherapeuticsBupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo‐controlled study
145 Citations2001David Gonzales, Mitchell Nides +9 more
The effect of repeated use of bupropion SR (Zyban; INN, amfebutamone) on abstinence rates has not been studied previously.
Archives of Family MedicinePharmacotherapy of Smoking Cessation
100 Citations2000Kolawole S. Okuyemi
Physicians, especially those in primary care specialties, should familiarize themselves with approved medications, benefits, adverse effects, and appropriate use of these products to improve efforts to help their patients stop smoking.
Clinical TherapeuticsLate-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo
85 Citations2001Brenda D. Jamerson
Among patients who initially failed treatment, continued therapy with bupropion SR, either alone or in combination with the nicotine patch, resulted in significantly higher short- and long-term smoking cessation rates than treatment with the Nicotine patch alone or placebo.
PubMedBupropion sustained release and smoking cessation.
78 Citations1998Michael G. Goldstein
The release of bupropion SR as a treatment for smoking cessation may provide clinicians with additional opportunities to address smoking cessation with their patients.
American Journal of Preventive MedicineThe Role of Tobacco Intervention in Population-Based Health Care:A Case Study
52 Citations1998Tim McAfee
A population-based model for smoking that contributed to a decrease from 25% to 15.5% in smoking prevalence in 10 years among its more than 550,000 adult enrollees in western Washington may have application to other arenas where health systems can support beneficial behavior change.
Preventive MedicineBupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting☆☆Research supported by Grant CA71358 from the National Cancer Institute to SRI International. Bupropion SR provided by Group Health Cooperative Pharmacy.
31 Citations2003Lisa M. Jack, Gary E. Swan +5 more
The methods used in this field trial show that it is possible to enroll subjects in an effectiveness trial that is successful from the standpoint of the consumer, provider, and health care system.
Preventive MedicineAids to Quitting Tobacco Use: How Important Are They Outside Controlled Trials?
19 Citations2001Leif I. Solberg, Raymond Boyle +4 more
Pharmacotherapeutic quit aids are being widely used, even in the absence of significant insurance coverage, with good evidence that several pharmacotherapies and counseling can effectively facilitate smoking cessation.